Business Context and Reporting Period
This Form 6-K filing by Intercure Ltd. covers the month of March 2026, specifically dated March 3, 2026. The registrant is a Foreign Private Issuer based in Herzliya, Israel, reporting under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a regulatory notification and does not contain financial statements or performance data.
Material Changes
The primary material event disclosed is the receipt of a notification from Nasdaq regarding the company's failure to meet the Minimum Bid Requirement. No other material changes to operations or financial status are detailed in this specific filing.
Guidance, Outlook, and Risks
- Regulatory Risk: The company faces potential delisting or compliance issues if it cannot regain compliance with Nasdaq's minimum bid price rules.
- Management Commentary: The filing references a press release (Exhibit 99.1) titled "InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement" but does not include the text of the commentary within the Form 6-K body.
- Unusual Items: The notification itself is the unusual item driving this filing.
Investor Verification Checklist
- Verify the current stock price and the specific duration of the non-compliance period with Nasdaq.
- Review the full text of the press release (Exhibit 99.1) for details on the company's plan to regain compliance.
- Check for any subsequent filings regarding a hearing request or extension of time granted by Nasdaq.
- Confirm if the company has announced any reverse stock split or other corporate actions to address the bid price requirement.